Rani Therapeutics Holdings (RANI) Accumulated Depreciation & Amortization (2020 - 2024)
Historic Accumulated Depreciation & Amortization for Rani Therapeutics Holdings (RANI) over the last 5 years, with Q4 2024 value amounting to $2.7 million.
- Rani Therapeutics Holdings' Accumulated Depreciation & Amortization rose 22896.25% to $2.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $2.7 million, marking a year-over-year increase of 22896.25%. This contributed to the annual value of $2.7 million for FY2024, which is 22896.25% up from last year.
- Per Rani Therapeutics Holdings' latest filing, its Accumulated Depreciation & Amortization stood at $2.7 million for Q4 2024, which was up 22896.25% from -$2.1 million recorded in Q4 2023.
- Over the past 5 years, Rani Therapeutics Holdings' Accumulated Depreciation & Amortization peaked at $2.7 million during Q4 2024, and registered a low of -$2.1 million during Q4 2023.
- Its 5-year average for Accumulated Depreciation & Amortization is -$831400.0, with a median of -$1.6 million in 2022.
- In the last 5 years, Rani Therapeutics Holdings' Accumulated Depreciation & Amortization plummeted by 3286.53% in 2023 and then surged by 22896.25% in 2024.
- Quarter analysis of 5 years shows Rani Therapeutics Holdings' Accumulated Depreciation & Amortization stood at -$1.6 million in 2020, then rose by 6.48% to -$1.5 million in 2021, then fell by 1.56% to -$1.6 million in 2022, then crashed by 32.87% to -$2.1 million in 2023, then surged by 228.96% to $2.7 million in 2024.
- Its Accumulated Depreciation & Amortization was $2.7 million in Q4 2024, compared to -$2.1 million in Q4 2023 and -$1.6 million in Q4 2022.